A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Eisai Clinical Trials

Protocol # E2007-A001-206

Study Overview

Study Compound: E2007

Drug Name: perampanel

Registry #: NCT00144690, EU CTR 2005-004199-18

Trial Period: Mar 2005 - Feb 2007

Indication: Epilepsy

Primary Endpoint: Determination of the maximum tolerated dose (MTD)

Population
Males and females (age 18 to 70 years)
Study Status
Completed
Study Phase
Phase 2
Countries
Australia, Czech Republic, Germany, Lithuania, Sweden, United Kingdom, United States See moreSee less

Results

CSR Synopsis

No download available

Lay Summary

No download available

Publication reference citation

Krauss GL, Bar M, Biton V, Klapper JA, Rektor I, Vaiciene-Magistris N, et al. Tolerability and safety of perampanel: Two randomized dose-escalation studies. Acta Neurol Scand 2012 01;125(1):8-15. DOI: 10.1111/j.1600-0404.2011.01588.x

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

Redacted documents are available upon request for this study.

Document type	Availability
Protocol
SAP
Sample CRF
Full CSR